Search Results - "Enyedi, Lajos"

Seven-year outcomes following intensive anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration by Lukacs, Regina, Schneider, Miklos, Nagy, Zoltan Zsolt, Sandor, Gabor Laszlo, Kaan, Kinga, Asztalos, Antonia, Enyedi, Lajos, Pek, Gyorgy, Barcsay, Gyorgy, Szabo, Antal, Borbandy, Agnes, Kovacs, Illes, Resch, Miklos Denes, Papp, Andras

“…Anti-vascular endothelial growth factor (VEGF) therapy is currently the most effective therapy of exudative age-related macular degeneration (AMD). The aim of…”
Get full text

Biosimilar SB15 versus reference aflibercept in neovascular age-related macular degeneration: 1-year and switching results of a phase 3 clinical trial by Sadda, SriniVas R, Bradvica, Mario, Vajas, Attila, Sagong, Min, Ernest, Jan, Studnička, Jan, Veith, Miroslav, Wylegala, Edward, Patel, Sunil, Yun, Cheolmin, Orski, Michal, Astakhov, Sergei, Tóth-Molnár, Edit, Csutak, Adrienne, Enyedi, Lajos, Choi, Wooree, Oh, Inkyung, Jang, Hyerin, Woo, Se Joon

“…Background/aimsTo evaluate efficacy, safety, pharmacokinetics (PK) and immunogenicity of SB15 versus reference aflibercept (AFL), and switching from AFL to…”
Get full text

Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration: A Phase 3 Randomized Clinical Trial by Woo, Se Joon, Bradvica, Mario, Vajas, Attila, Sagong, Min, Ernest, Jan, Studnicka, Jan, Veith, Miroslav, Wylegala, Edward, Patel, Sunil, Yun, Cheolmin, Orski, Michal, Astakhov, Sergei, Tóth-Molnár, Edit, Csutak, Adrienne, Enyedi, Lajos, Kim, Taehyung, Oh, Inkyung, Jang, Hyerin, Sadda, SriniVas R

“…Aflibercept biosimilars can expand available treatment options in retinal diseases and have the potential to improve patient access to safe and effective…”
Get more information